Emerging evidence suggests that microRNAs (miRNAs) serve an important role in tumorigenesis and development. Although the low expression of miR-125a-5p in gastric cancer has been reported, the underlying mechanism remains unknown. In the current study, the low expression of miR-125a-5p in gastric cancer was verified in paired cancer tissues and adjacent non-tumour tissues. Furthermore, the GC islands in the miR-125a-5p region were hypermethylated in the tumour tissues. And the hypermethylation was negatively correlated with the miR-125a-5p expression.
Among all the dysregulated miRNAs, miR-125a-5p is one of the most down-regulated or mutated miRNAs in gastric cancer tissues. 9 A number of studies have shown that the microRNA-125a-5p is an important tumour suppressor, and its expression is reduced in many types of human cancer, including in laryngeal cancer, 10 juvenile angiofibromas, 11 colorectal cancer, 12 breast cancer, 13, 14 lung cancer, [15] [16] [17] cervical carcinomas, 18 prostate and pancreatic cancers. 19 MicroRNA-125a-5p has been demonstrated as an independent prognostic factor in gastric cancer and inhibiting the gastric cancer development, 20 through targeting oncogenes such as vascular endothelial growth factor A 21 and E2F transcription factor 3. 22 Overexpressing miR-125a-5p could inhibit the cancer proliferation and migration. 23, 24 However, the underlying mechanism of the low expression of miR-125a-5p in gastric cancer remains unknown. It has been demonstrated that some epigenetic modulators could modulate the miR-125-5p expression, such as HDACs (histone deacetylases), 13, 25 or be modulated by miR-125-5p, such as Sirtuins. 26 Furthermore, the putative promoter regions the miR-125a-5p are embedded in CpG islands and are hypermethylated in glioma cells. 27 Considering the above findings, we wanted to test the expression and methylation status of miR-125a-5p in gastric cancer tissues and adjacent non-tumour tissues and then to evaluate whether DNA methylation participates in regulating miR-125a-5p expression in human gastric cancer.
In this study, it was confirmed that the miR-125a-5p expression was reduced in most gastric cancer tissues comparing with the adjacent non-tumour tissues. DNA methylation analysis showed the miR125a-5p promoter was highly methylated and negatively associated its expression. Target gene screening and validation showed that the histone methyltransferase Suv39H1 was the miR-125a-5p target gene, which was also involved into the epigenetic silencing of the miR-125a-5p. Overexpessing miR-125a-5p could self-activate the silenced miR-125a-5p in gastric cancer cells, resulting in cancer suppression in vitro and in vivo. The data here showed that the miR125a-5p might be not only the potential prognostic value as a tumour biomarker but also potential therapeutic targets in gastric cancer.
| ME TH ODS AND MATERIALS

| Patients
The clinical characteristics of all 286 patients in our study are listed in 
| RNA isolation and RT-qPCR
Total RNA from tissues or cultured cells was isolated using TRIzol reagent (Thermo Fisher Scientific) according to the manufacturer's protocol. RNA concentration was measured using NanoDrop ND-1000 (Thermo Fisher Scientific), and the quality was assessed using electrophoresis with 1.5% denaturing agarose gels. TaqMan probebased qPCR was performed using a commercial kit (Applied Biosystems, Thermo Fisher Scientific) according to the manufacturer's protocol. Reverse transcription was performed using a miR-125a-5p-specific primer and ABI's TaqMan MicroRNA Reverse Transcription kit (Applied Biosystems, Thermo Fisher Scientific). miR-125a-5p expression level was detected using a Taqman MicroRNA assay (Applied Biosystems, Thermo Fisher Scientific) with the Applied Biosystems 7900HT Sequence Detection system. U6 was used as the internal con- 
| Cell culture and transfection
Primary gastric cancer cell line GC-114 and GC-026 were isolated from gastric cancer tissues. The cell line HEK293T and gastric cancer cell line NCI-N87 were purchased from China Center for type culture collection in Wuhan. All cells were cultured with RPMI-1640 medium (Gibco) containing 10% foetal bovine serum (FBS) (Gibco).
MicroRNA was transfected at 30 nmol/L (final concentration) using Lipofectamine ™ RNAiMAX (Thermo Fisher Scientific) according to the manufacturer's instructions.
| Luciferase reporter assay
The 3 0 -UTR of human Suv39H1 containing the potential miR-125a-5p binding sites was amplified by high fidelity PCR. Then, the amplified sequence was cloned into the XbaI site of the pGL3 control vector (Promega). The mutated putative miR-125a-5p binding site in the 3 0 -UTR of Suv39H1 was generated using the QuickChange Site- 
| Cell viability assay
Cell viability was evaluated using CCK-8 ( 
| Cell apoptosis assay
Cell apoptosis was evaluated by flow cytometry using an Annexin V- 
| Cell migration assay
The migration of cells was detected by wound-healing assay. Cells were cultured in 6-well plates. When the cells grew to 80%-90%
confluence, a wound in a line across the well was made by a plastic pipette tip. The area of cell-free wound was recorded 24 hours later using an inverted microscope and analysed by the NIH Image 1.55
software. Wound healing = 1009 (1-the remaining cell-free area/the area of the initial wound). All tests were performed in triplicate.
| Transwell invasion assay
Invasive ability of cells was determined within a transwell system. 
| Lentivirus preparation
The miR-125a-5p was cloned into lentiviral pLKO.1-puro vector and the empty vector as negative control. Lentiviruses were prepared using HEK293T cells according to the manufacturer's instructions.
GC-026 cells were incubated with lentivirus and 4 mg/mL polybrene (AmericanBio) for 24 hour.
| Animal study
Six-to week-old NOD/SCID mice (Charles River Laboratories, Beijing, China) were housed in specific pathogen-free conditions. The 
| Statistical analysis
| RESULTS
| Decreased miR-125a-5p level in gastric cancer biopsies
A total of 286 cases with gastric cancer were followed. All these patients had received no pre-operation chemotherapy. They were given the same radical operation and underwent the same adjuvant chemotherapy after the surgery. The miR-125a-5p level was firstly analysed and the data showed that the miR-125a-5p level reduced significantly in gastric cancer tissues comparing with its paired adjacent non-cancerous tissues ( Figure 1A ). The reduced miR-125a-5p level was associated with tumour size (P = .001), lymph node (P = .009) and liver metastasis (P = .012, Table 1 ).
Disease-free survival (DFS) and overall survival (OS) were conducted to assess the predictive role of miR-125a-5p level for metastasis. Both DFS and OS were significantly higher in the high miR125a-5p level group than the low miR-125a-5p level group (Figure 1B) . The low miR-125a-5p level group subsequently developed more metastasis than the high miR-125a-5p level group (P < .05, Table 1 ). Univariate and multivariate analysis showed that patients with reduced miR-125a-5p level had a significantly reduced OS and DFS (Tables 2 and 3 ).
It has been demonstrated that the epigenetic modulators could modulate the miR-125-5p expression, 13, 25, 26 and its promoter is hypermethylated in glioma cells. 27 We analysed the miR-125a-5p methylation status in gastric cancer tissues and adjacent non-tumour tissues. We designed and validated bisulphate sequencing PCR for the promoter region of miR-125a-5p including 20 CpGs. Data showed that the miR-125a-5p was hypermethylated in gastric cancer tissues comparing with the adjacent non-cancer tissues ( Figure 1C ).
To further determine whether DNA methylation contributes to the silencing of miR-125a-5p in gastric cancer, the correlation between the miR-125a-5p and its methylation level was analysed. And the methylation status was negatively correlated with its expression level ( Figure 1D ).
Taken together, the data showed that the epigenetic silenced miR-125a-5p might contribute to gastric cancer development and the poor outcomes.
| Suv39H1 is directly regulated by miR-125a-5p
To uncover the potential mechanism of the epigenetic silencing of miR-125a-5p in gastric cancer cells, the potential targets of miR125a-5p were screened using prediction tools including miRanda, TargetScan and Pictar algorithms. Among the hundreds of targets that were predicted, the histone methyltransferase Suv39H1 was further studied. To obtain the direct evidence that Suv39H1 is a potential target of miR-125a-5p, we examined whether the predicted binding sites of miR-125a-5p in the 3 0 -UTR of Suv39H1 mRNA were responsible for its regulation (Figure 2A ). The 3 0 -UTR of Suv39H1 was cloned into the downstream of a luciferase reporter, and this vector was co-transfected with an miR-125a-5p mimic or its negative control into HEK293T cells. The luciferase activity of cells transfected with miR-125a-5p mimic was significantly reduced compared with the negative control (P < .05; Figure 2B ). Furthermore, deletion of the putative binding site clearly abrogated the repression of luciferase activity caused by miR-125a-5p overexpression ( Figure 2B ).
If the Suv39H1 is regulated by miR-125a-5p in gastric cancer, the Suv39H1 expression level in gastric cancer tissue should be upregulated as the down-regulation of miR-125a-5p. As expected, the mRNA level of Suv39H1 was up-regulated in gastric cancer tissue comparing with the adjacent non-tumour tissues ( Figure 2C ). This was further validated in two primary isolated gastric cancer cell lines:
GC-114 and GC-026. After overexpressing miR-125a-5p, the mRNA and protein levels of Suv39H1 were suppressed significantly ( Figure 2D ,E). This was further validated in the well established gastric cancer cell line NCI-N87 ( Figure S1 ).
These data suggested that miR-125a-5p might inhibit the Suv39H1 expression through 3 0 -UTR in gastric cancer tissues, and affect the epigenetic status of the cancer cells.
| Demethylation and activation of endogenous miR-125a-5p through exogenous overexpressing miR-125a-5p
Because Suv39H1 is a histone-lysine N-methyltransferase that specifically trimethylates Lys-9 of histone H3 (H3K9me3), we first determined whether overexpressing miR-125a-5p would affect the H3K9 trimethylation (H3K9me3) status through targeting Suv39H1.
As expected, the whole genome H3K9me3 level was decreased after overexpressing miR-125a-5p ( Figure 3A) . The H3K9me3 is also tightly related to the DNA methylation. Thus, we then measured the miR-125a-5p methylation level after miR-125a-5p overexpression.
Interestingly, the methylation level was decreased by overexpressing miR-125a-5p ( Figure 3B) . Furthermore, the endogenous miR-125a-5p precursor was also up-regulated ( Figure 3C ). This up-regulation and demethylation of miR-125a-5p were abolished when overexpressing miR-125a-5p and Suv39H1 together ( Figure 3D-F) , indicating that miR-125a-5p could modulate its own methylation and expression through Suv39H1. This was further validated in the wellestablished gastric cancer cell line NCI-N87 ( Figure S2 ).
| Overexpression of miR-125a-5p inhibits gastric cancer cell activities
It has been demonstrated that miR-125a-5p functions as tumour suppressor and our data also showed that its expression decreased in the gastric cancer specimens. Thus, we further evaluated the antitumour effects of miR-125a-5p in vitro. Two gastric cancer cell lines isolated from gastric cancer specimens were used. And our data showed that overexpressing miR-125a-5p could inhibit the gastric cancer cell migration ( Figure 4A ), invasion ( Figure 4B ) and proliferation ( Figure 4C ). In addition, the miR-125a-5p could accelerate the F I G U R E 1 Reduced miR-125a-5p is correlated with the poor prognosis of gastric cancer. A, miR-125a-5p levels in cancer tissues and adjacent normal tissues were determined by qPCR (n = 286).
Result is depicted as box plots; middle line indicates median; bottom of box, 25th percentile; and top of box, 75th percentile. *P < .05. B, Kaplan-Meier survival curve of patients with high or low level of miR125a-5p. C, miR-125a-5p methylation levels in cancer tissues and adjacent normal tissues were determined (n = 286).
Result is depicted as box plots; middle line indicates median; bottom of box, 25th percentile; and top of box, 75th percentile. *P < .05. D, Correlation between the mRNA level and the methylation level of miR-125a-5p. Inset corresponds to Pearson's R correlation and corresponding P value gastric cancer cell apoptosis ( Figure 4D ). This was further validated in the well-established gastric cancer cell line NCI-N87 ( Figure S3 ).
| Overexpressing miR-125a-5p suppresses gastric cancer development in vivo
To further confirm the important role of miR-125a-5p level on gastric cancer development, human gastric cancer cell line GC-026 was firstly infected with lentivirus expressing miR-125a-5p. Then, the cells were transplanted subcutaneously into the dorsal scapula region of the NOD/SCID mice. Data showed that overexpressing miR125a-5p inhibited gastric cancer development in vivo ( Figure 5A ).
Furthermore, exogenous miR-125a-5p overexpression could decrease the endogenous miR-125a-5p methylation level ( Figure 5B) and also promotes its precursor expression ( Figure 5C ). The Suv39H1 level was also decreased after miR-125a-5p overexpression ( Figure 5D ). These data showed that overexpressing miR-125a-5p inhibited gastric cancer development in vivo through suppressing Suv39H1 expression, resulting in endogenous miR-125a-5p demethylation and up-regulation. Furthermore, miR-125a-5p has been validated to prevent the cancer cell progression. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] 23, 24 However, the underlying mechanism of the low expression of miR-125a-5p in gastric cancer remains unknown.
In the present study, it was further confirmed that the miR125a-5p expression was reduced in most gastric cancer tissues comparing with the adjacent non-tumour tissues. And the down-regulation was tightly correlated with the low overall survival and disease-free survival. DNA methylation analysis showed that the miR-125a-5p promoter was highly methylated and negatively associated its expression. Aberrant promoter methylation is consid- 
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F I G U R E 4 Increasing miR-125a-5p levels suppressed gastric cancer cell activities. A, Wound-healing assay with overexpressing miR-125a-5p or empty vector (NC) in two primary gastric cancer cell line (GC-114 and GC-026). n = 3. *P < .05. B, Cell invasion assay with overexpressing miR-125a-5p or empty vector (NC) in two primary gastric cancer cell line (GC-114 and GC-026). n = 3. *P < .05. C, The survival rate analysis with overexpressing miR-125a-5p or empty vector (NC) in two primary gastric cancer cell line (GC-114 and GC-026). n = 3. *P < .05. D, The cell apoptosis analysis with overexpressing miR-125a-5p or empty vector (NC) in two primary gastric cancer cell line (GC-114 and GC-026). n = 3. *P < .05 F I G U R E 3 Demethylation and activation of endogenous miR-125a-5p through exogenous overexpressing miR-125a-5p. A, Overexpressing miR-125a-5p could suppress the H3K9me3 level in two primary gastric cancer cell line (GC-114 and GC-026), determined by Western blot. B, Overexpressing miR-125a-5p could suppress the miR-125a-5p methylation levels in two primary gastric cancer cell line (GC-114 and GC-026). n = 3. *P < .05. C, Overexpressing miR-125a-5p could up-regulate the endogenous miR-125a-5p precursor expression in two primary gastric cancer cell line (GC-114 and GC-026), determined by qPCR. n = 3. *P < .05. D, Successful overexpression of Suv39H1 in two primary gastric cancer cell line (GC-114 and GC-026), determined by Western blot. E, Up-regulation of endogenous miR-125a-5p precursor by exogenous miR-125a-5p overexpression could be abolished by Suv39H1 overexpression in two primary gastric cancer cell line (GC-114 and GC-026), determined by qPCR. n = 3. *P < .05. F, The demethylation of miR-125a-5p by exogenous miR-125a-5p overexpression could be abolished by Suv39H1 overexpression in two primary gastric cancer cell line (GC-114 and GC-026). n = 3. *P < .05. NC: empty vector window of therapeutic opportunity. The development of modified miRNAs with longer half-time and higher efficiency has produced favourable anticancer outcomes in experimental models, including the locked nucleic acid modified oligonucleotides and the antisense oligonucleotides. [4] [5] [6] Therefore, enforced expression of miR-125a-5p
utilizing approaches such as transfection of miR-125a-5p-carrying viruses or synthetic miR-125a-5p oligos will be required for future study in gastric carcinoma pathology.
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The authors declare that they have sno competing interests. F I G U R E 5 Overexpressing miR-125a-5p suppressed gastric cancer development in vivo. A, Overexpressing miR-125a-5p decreased the tumour size in vivo. n = 12. *P < .05. B, Overexpressing miR-125a-5p decreased the methylation level of miR-125a-5p in vivo. n = 12. *P < .05. C, Overexpressing miR-125a-5p increased the expression of endogenous miR-125a-5p precursor in vivo. n = 12. *P < .05. D, Overexpressing miR-125a-5p suppressed the expression of Suv39H1 in vivo. n = 12. *P < .05. NC: empty vector
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